A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The Purpose of this study is to evaluate the safety and efficacy of MP03-36 (0.15% azelastine
hydrochloride)at dosages of 2 sprays per nostril once daily and 2 sprays per nostril twice
daily in patients with seasonal allergic rhinitis.